Performance analysis of Heron Therapeutics (HRTX)
Annual Return
Over the past 3 years, HRTX has had an average annual return of -29.22%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, HRTX has had an average annual return of -48.19%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, HRTX has had an average annual return of -29.76%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Nov 1, 1999, HRTX has had an average annual return of -21.40%, underperforming the benchmark SPY, which returned +8.46% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -62.79% | -14.00% | -10.71% | -31.71% | -72.58% | -56.92% | -9.87% | -9.41% | +43.34% | +38.23% | -50.97% | +165.15% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| +13.01% | -18.21% | +136.42% | -48.99% | -64.16% | +200.36% | -73.46% | -71.17% | -10.47% | -7.26% | -32.65% | +144.95% |
| 2002 | 2001 | 2000 | 1999 | ||||||||
| -64.28% | +17.88% | -30.92% | -9.83% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | -9.30% | -33.33% | +50% | -25.64% | -51.72% | +14.29% | -62.79% | |||||
| 2025 | +12% | +44.64% | -11.11% | +9.72% | -21.52% | +9.68% | -16.18% | -22.81% | -6.82% | -7.32% | +0% | +13.16% | -14.00% |
| 2024 | +41.07% | +10.13% | +4.60% | -16.48% | +59.21% | -4.96% | -15.65% | -35.05% | +3.17% | -12.31% | -31.58% | +28.21% | -10.71% |
| 2023 | +8.54% | -12.36% | -35.90% | +56% | -52.56% | +2.70% | +42.11% | -0% | -37.04% | -38.24% | +90.48% | +40% | -31.71% |
| 2022 | -4.35% | -18.53% | -19.31% | -21.28% | -27.03% | -15.74% | +0% | +47.25% | +2.99% | -8.70% | -29.37% | -7.87% | -72.58% |
| 2021 | -18.01% | +4.22% | -10.46% | +7.91% | -24.08% | +17.01% | -20.43% | -5.43% | -8.62% | +3.14% | -14.13% | -3.55% | -56.92% |
| 2020 | -11.17% | -10.67% | -36.99% | +21.30% | +27.84% | -19.26% | +10.79% | -12.17% | +3.62% | +10.08% | +6.17% | +22.18% | -9.87% |
| 2019 | +3.76% | -1.59% | -7.72% | -11.24% | -21.52% | +9.14% | -6.08% | +6.12% | -0.16% | +15.02% | +20.23% | -8.11% | -9.41% |
| 2018 | +19.73% | -6.06% | +35.68% | +9.72% | +7.65% | +19.18% | -3.61% | +2.93% | -17.88% | -12.33% | +3.52% | -9.77% | +43.34% |
| 2017 | -0.70% | +10.09% | +4.90% | +2.24% | -12.72% | +3.42% | +14.54% | +4.04% | -2.22% | -4.91% | +14.71% | +2.77% | +38.23% |
Drawdown analysis of Heron Therapeutics (HRTX)
The maximum drawdown for the HRTX was -99.91%, occurring on Jun 9, 2026. This drawdown has not yet recovered.
The current HRTX drawdown is -99.89%.
Since Nov 1, 1999 HRTX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.91% | Mar 9, 2000 | 6601 | Jun 9, 2026 | Ongoing | Ongoing | Ongoing |
| -30.17% | Nov 3, 1999 | 23 | Dec 7, 1999 | 23 | Jan 10, 2000 | 46 |
| -16.43% | Jan 10, 2000 | 14 | Jan 31, 2000 | 6 | Feb 8, 2000 | 20 |
| -14.62% | Mar 3, 2000 | 2 | Mar 7, 2000 | 2 | Mar 9, 2000 | 4 |
| -13.52% | Feb 9, 2000 | 5 | Feb 16, 2000 | 11 | Mar 3, 2000 | 16 |
| -1.65% | Nov 1, 1999 | 1 | Nov 2, 1999 | 1 | Nov 3, 1999 | 2 |